how are glp 1 drugs administered GLP-1 Medications: Everything You Need to Know Weighing benefits, risks of GLP-1

We selected appropriate confounders, such as index year, sex, age, diabetes duration, health screening variables, comorbidities, and antidiabetic drugs, for PS matching to minimize the influence of factors other than GLP-1 RA exposure

Tirzepatide is also less effective at reducing body weight in T2D patients compared to patients without (15.7% weight loss, SURMOUNT-2 and 22.5% weight loss, SURMOUNT-1, respectively)

John M, Kalra S, Nair T

According to a report from the WHO, in 2022, ~830 million people worldwide had diabetes, and over 95% of diabetes cases are type 2

Glucose-Dependent Insulinotropic Polypeptide Inhibits Cardiac Hypertrophy and Fibrosis in Diabetic Mice via Suppression of TGF-2

These therapies, initially designed for type 2 diabetes, have demonstrated significant weight loss benefits, leading to their expanded use in obesity management